The 4 Pulmonology Conditions Every FNP Student Must Master Before Board Day
Pulmonology · 4 min read · September 10, 2026
Pulmonology questions make up a substantial portion of both the AANP and ANCC family nurse practitioner certification exams. When you sit down for your test, you will not just be asked to recall textbook definitions; you will be expected to differentiate between overlapping respiratory presentations and choose the safest, most evidence-based management strategy. Let us break down the four most high-yield pulmonology topics you need to conquer before exam day.
1. Asthma vs. COPD: Spotting the Key Differences
Both asthma and COPD involve chronic airway obstruction, but their underlying pathology and initial management strategies differ significantly. Asthma is characterized by reversible airway hyper-responsiveness and inflammation, whereas COPD features progressive, largely irreversible airflow limitation driven by chronic bronchitis and emphysema.
On your boards, look for the patient's age of onset, smoking history, and reversibility on spirometry. An FEV1/FVC ratio of less than 0.70 post-bronchodilator is the hallmark diagnostic threshold for COPD.
- Board Tip: Never prescribe a long-acting beta-agonist (LABA) as monotherapy for asthma; it is associated with an increased risk of asthma-related death. LABAs must always be combined with an inhaled corticosteroid (ICS) in asthma, whereas LABAs or long-acting muscarinic antagonists (LAMAs) can be used as monotherapy in COPD.
2. Community-Acquired Pneumonia (CAP): Outpatient Management and Antibiotic Stewardship
Community-acquired pneumonia is a classic board exam scenario. You will be given a patient presenting with a productive cough, fever, dyspnea, and focal lung findings like dullness to percussion and egophony. The key board challenge is knowing when to treat empirically and which pathogens to cover.
For a previously healthy outpatient with no recent antibiotic use within the past 90 days, first-line therapy options include amoxicillin, doxycycline, or a macrolide (if local pneumococcal resistance is less than 25%). If the patient has comorbidities like heart, lung, liver, or renal disease, or diabetes, you must step up coverage to a combination therapy (such as augmentin plus a macrolide or doxycycline) or a respiratory fluoroquinolone (like levofloxacin).
- Clinical Pearl: Always check the patient's recent medication history. If they took an antibiotic within the last 3 months, select an agent from a different class to avoid treatment failure due to resistant Streptococcus pneumoniae.
3. COPD Exacerbations: When to Add Steroids and Antibiotics
Managing a stable COPD patient is very different from managing an acute exacerbation. When a patient reports increased dyspnea, sputum volume, and sputum purulence, they are experiencing an acute exacerbation.
Board questions will test whether you know when to add systemic corticosteroids and antibiotics. Systemic corticosteroids (such as oral prednisone for 5 days) reduce recovery time and improve lung function. Antibiotics should be initiated if the patient exhibits all three cardinal symptoms or has moderate-to-severe exacerbations requiring mechanical ventilation, or if purulent sputum is present alongside at least one other cardinal symptom.
- Board Tip: Azithromycin is unique because it possesses both anti-inflammatory and anti-bacterial properties, making it a preferred choice for chronic maintenance in select frequent exacerbators, as well as a great option during acute episodes.
4. Recognizing Pulmonary Embolism: Wells Criteria and Beyond
Acute pulmonary embolism (PE) can mimic many other cardiopulmonary conditions, making it a favorite topic for board examiners who want to test your clinical safety. Classic presentation includes sudden-onset dyspnea, pleuritic chest pain, and tachycardia. Risk factors include immobility, recent surgery, malignancy, and hypercoagulable states.
You must know how to apply clinical prediction rules like the Wells Criteria for PE to stratify risk into low, moderate, or high probability. For low-to-intermediate risk, a negative high-sensitivity D-dimer safely rules out PE. For high risk, or when D-dimer is elevated, a CT pulmonary angiography (CTPA) is the gold standard diagnostic imaging.
- Clinical Pearl: If a pregnant patient presents with suspected PE, remember that a ventilation-perfusion (V/Q) scan or lower extremity ultrasound is often preferred initially over a CT angiography to minimize fetal radiation exposure to maternal breast tissue.
You have got what it takes to master these respiratory concepts and crush your board exam. Trust the clinical framework you are building every single day, keep your study sessions focused, and remember that every practice question brings you one step closer to your FNP cap. Head over to thefnpreview.com to access thousands of high-yield practice questions and take the guesswork out of your board prep.